Conavi Medical Corp.
CNVI.V
TSX
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -75.89% | 257.88% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -75.89% | 257.88% | |||
| Cost of Revenue | -25.18% | 291.82% | |||
| Gross Profit | -97.43% | -1,045.95% | |||
| SG&A Expenses | 4.49% | 45.88% | |||
| Depreciation & Amortization | -24.82% | -29.72% | |||
| Other Operating Expenses | 23.94% | -- | |||
| Total Operating Expenses | -12.15% | 45.13% | |||
| Operating Income | -9.59% | -41.34% | |||
| Income Before Tax | -124.18% | -109.98% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -124.18% | -109.98% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -124.18% | -109.98% | |||
| EBIT | -9.59% | -41.34% | |||
| EBITDA | -9.50% | -44.91% | |||
| EPS Basic | -123.82% | -109.87% | |||
| Normalized Basic EPS | -31.05% | -67.79% | |||
| EPS Diluted | -123.82% | -109.87% | |||
| Normalized Diluted EPS | -31.05% | -67.79% | |||
| Average Basic Shares Outstanding | 0.15% | 0.05% | |||
| Average Diluted Shares Outstanding | 0.15% | 0.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
